208,077.7 713.9 Operating expenses 6,802.3 23.3 12,257.5 42.1 15,095.5 51.8 Depreciation and Amortization 35,526.0 121.9 38,421.0 131.8 38,426.6 131.8 Financial Cost - - 7.3 0.0 156.4 0.5 Net Profit 117,967.8
. 3. Performance of the Company Operating Results The Company reported a net profit of Baht 3,345 million compared to loss of Baht 1,810 million last year as explained above. The consolidated post net
their operating costs, transfer fee of drug registration to be paid to government agencies that should be responsible by seller บร ิษัท อ ินเตอร ์ฟารม์า จาํกัด (มหาชน) เลขท ี / อาคารไอทเีอฟ ชัน ถนนสีลม
parent 63.6% 60.0% 63.0% 58.9% 61.2% Remark: * EBITDA = Earnings before interest, taxes, depreciation and amortization - non-operating income / (expense) ** Normalized net profit = Net profit – unrealized
disposed percentage, divided by net profit of the Company Calculation cannot be made given each of the Company, UAB and SBM has operating losses n.a. 3. Total consideration Total consideration paid or
company and its subsidiaries’ operating result for the 1st quarter ended 31st March 2020 Unit: THB Million Q1/2020 Q4/2019 QoQ Q1/2019 YoY Total Revenue 43,070 50,146 -14% 45,535 -5% Accounting EBITDA
Bangchak Corporation Plc. I 3 Executive Summary Summary of the Company and its subsidiaries’ operating results for the quarter ended 30th September 2019 Unit: THB Million Q3/2019 Q2/2019 QoQ Q3/2018 YoY
subscribers. To give order under the first paragraph, the SEC Office shall take the following factors into consideration: (1) severity of the facts or circumstance that have been changed; (2) impact on investor
Part 1; (2) Filing of the Registration Statement for an Offer for Sale of Depositary Receipts under Part 2; (3) Ongoing Disclosure of Information on Financial Position and Operating Results of the Issuer
index calculation and guidelines for managing the fund in case of such circumstances. (2) Information on the price or the operating results of the goods or the underlying during at least the past three